Advertisement
Advertisement
VRDN
Viridian Therapeutics, Inc. Common Stock
18.46
USDSponsored
+0.56
+3.12%
Jun 29, 11:47 UTC -4
Open
Viridian Therapeutics, Inc. Common Stock Profile
About
Info & Links
CEO
Stephen Mahoney
Headquarters
WALTHAM, MA 02453, UNITED STATES
Industry
Sector
Website
Auditor
KPMG LLP
Share holders
9
Employees
252
Viridian Therapeutics, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
2.04B
Enterprise Value
1.91B
Enterprise Value/EBITDA(ttm)
-4.88
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
22.19
Price to Book(mrq)
2.49
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-483.57%
Profit Margin(ttm)
-86562.98%
Return on Equity(ttm)
-83.25%
Return on Invested Capital(ttm)
-55.19%
Return on Assets(ttm)
-50.38%
Income Statement
Revenue(ttm)
70.92M
Revenue Per Share(ttm)
0.69
Gross Profit(ttm)
70.92M
EBITDA(ttm)3
-391.53M
Net Income Available to Common(ttm)
-360.59M
Diluted EPS(ttm)
-3.29
Share Statistics
Beta (5Y Monthly)
1.16
52-Week Change
28.81%
S&P 500 52-Week Change
19.37%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
103.07M
Dividend Yield
0.00%
Float4
100.59M
% Held by Insiders
1.58%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
762.18M
Total Cash Per Share(mrq)
7.39
Total Debt(mrq)
50.44M
Total Debt/Equity(mrq)
6.92%
Current Ratio(mrq)
12.65%
Quick Ratio(mrq)
12.65%
Book Value Per Share(mrq)
7.09
Cash Flow
Operating Cash Flow Per Share(ytd)
-3.26
Free Cash Flow(ytd)
-276.89M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement